{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:42:24Z","timestamp":1782891744859,"version":"3.54.5"},"reference-count":23,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the ALF-agreement between the Swedish government and the county councils"},{"name":"The Marcus Borgstr\u00f6m Foundation"},{"name":"the Nilsson-Ehle Endowments"},{"name":"G and E Eriksson's foundation for cancer research"},{"name":"The Magnus Bergvall Foundation"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2023,7,28]]},"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Low-impact genetic variants identified in population-based genetic studies are not routinely measured as part of clinical genetic testing in familial breast cancer (BC). We studied the consequences of integrating an established Polygenic Risk Score (PRS) (BCAC 313, PRS<jats:sub>313<\/jats:sub>) into clinical sequencing of women with familial BC in Sweden.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We developed an add-on sequencing panel to capture 313 risk variants in addition to the clinical screening of hereditary BC genes. Index patients with no pathogenic variant from 87 families, and 1000 population controls, were included in comparative PRS calculations. Including detailed family history, sequencing results and tumour pathology information, we used BOADICEA (Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm) V.6 to estimate contralateral and lifetime risks <jats:italic>without<\/jats:italic> and <jats:italic>with<\/jats:italic> PRS<jats:sub>313<\/jats:sub>.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Women with BC but no pathogenic variants in hereditary BC genes have a higher PRS<jats:sub>313<\/jats:sub> compared with population controls (mean+0.78\u2009SD, p&lt;3e-9). Implementing PRS<jats:sub>313<\/jats:sub> in the clinical risk estimation before their BC diagnosis would have changed the recommended follow-up in 24%\u201345% of women.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our results show the potential impact of incorporating PRS<jats:sub>313<\/jats:sub> directly in the clinical genomic investigation of women with familial BC.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jmg-2023-109311","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T13:20:30Z","timestamp":1692019230000},"page":"150-154","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer"],"prefix":"10.1136","volume":"61","author":[{"given":"Panagiotis","family":"Baliakas","sequence":"first","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arielle R","family":"Munters","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"K\u00e4mpe","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Tesi","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden"},{"name":"Department of Clinical Genetics, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise","family":"Bondeson","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claes","family":"Ladenvall","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5473-3312","authenticated-orcid":false,"given":"Daniel","family":"Eriksson","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden"},{"name":"Department of Clinical Genetics, Akademiska Sjukhuset, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"key":"2025100511054141000_61.2.150.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/cku088"},{"key":"2025100511054141000_61.2.150.2","unstructured":"Cancer research UK. 2022. Available: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/breast-cancer"},{"key":"2025100511054141000_61.2.150.3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2025100511054141000_61.2.150.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61611-0"},{"key":"2025100511054141000_61.2.150.5","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0969"},{"key":"2025100511054141000_61.2.150.6","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32211"},{"key":"2025100511054141000_61.2.150.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2018.11.002"},{"key":"2025100511054141000_61.2.150.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-019-0459-4"},{"key":"2025100511054141000_61.2.150.9","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2022-108806"},{"key":"2025100511054141000_61.2.150.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-020-0884-4"},{"key":"2025100511054141000_61.2.150.11","unstructured":"Excellence TNIfHaC . Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. London: National Institute for Health and Care Excellence, 2019."},{"key":"2025100511054141000_61.2.150.12","unstructured":"Network NCC . NCCN guidelines version 1.2022 breast cancer screening and diagnosis. n.d. Available: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast-screening.pdf"},{"key":"2025100511054141000_61.2.150.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7112"},{"key":"2025100511054141000_61.2.150.14","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-021-00279-9","article-title":"Investigation of Monogenic causes of familial breast cancer: data from the BEACCON case-control study","volume":"7","author":"Li","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"2025100511054141000_61.2.150.15","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-20-1319"},{"key":"2025100511054141000_61.2.150.16","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2022-108502"},{"key":"2025100511054141000_61.2.150.17","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2017.130"},{"key":"2025100511054141000_61.2.150.18","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djab050"},{"key":"2025100511054141000_61.2.150.19","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1093\/hmg\/ddac102","article-title":"Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach","volume":"31","author":"Gao","year":"2022","journal-title":"Hum Mol Genet"},{"key":"2025100511054141000_61.2.150.20","doi-asserted-by":"crossref","DOI":"10.1016\/j.xgen.2022.100118","article-title":"Genome-wide risk prediction of common diseases across Ancestries in one million people","volume":"2","author":"Mars","year":"2022","journal-title":"Cell Genom"},{"key":"2025100511054141000_61.2.150.21","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17680-w","article-title":"European Polygenic risk score for prediction of breast cancer shows similar performance in Asian women","volume":"11","author":"Ho","year":"2020","journal-title":"Nat Commun"},{"key":"2025100511054141000_61.2.150.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0379-x"},{"key":"2025100511054141000_61.2.150.23","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-020-00202-8","article-title":"Contralateral breast cancer risk in patients with Ductal carcinoma in situ and invasive breast cancer","volume":"6","author":"Giardiello","year":"2020","journal-title":"NPJ Breast Cancer"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg-2023-109311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:05:49Z","timestamp":1759687549000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg-2023-109311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,19]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/jmg-2023-109311"],"URL":"https:\/\/doi.org\/10.1136\/jmg-2023-109311","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,14]]}}}